We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tyson Foods (TSN) Q3 Earnings Beat Estimates, Sales Miss
Read MoreHide Full Article
Tyson Foods, Inc. (TSN - Free Report) posted third-quarter fiscal 2020 results, wherein both earnings and sales declined year over year and the latter fell short of the Zacks Consensus Estimate. Results in the quarter were affected by coronavirus-led reduced production across all segments. Also, the company saw higher-than-usual operating costs in all segments due to COVID-19.
Nevertheless, earnings topped the consensus mark. Also, in a separate press release, management named Dean Banks as the company’s new CEO, who will succeed Noel White on Oct 3. Notably, Banks will continue to serve as the company’s president, while White will serve Tyson Foods as the executive vice chairman of the board of directors.
Shares of the company were up around 2% in the pre-market trading session on Aug 3. Further, this Zacks Rank #2 (Buy) stock has rallied 11.1% in the past three months compared with the industry’s growth of 8.2%.
Q3 in Detail
Adjusted earnings for the reported quarter were $1.40 per share, beating the Zacks Consensus Estimate of 90 cents. However, the bottom line declined 5% year over year.
Tyson Foods, Inc. Price, Consensus and EPS Surprise
Net sales declined 7.9% to $10,022 million. Also, the top line fell short of the Zacks Consensus Estimate of $10,605 million.
Gross profit for the quarter came in at $1,313 million, down 1.7% from the prior-year quarter. Tyson Foods’ adjusted operating income decreased 4.5% to $760 million. During the quarter, the company incurred $340 million as direct incremental expenses associated with COVID-19. These include escalated costs related to workers’ health, such as personal protection equipment, sanitization of production facilities, testing for coronavirus, various professional fees and bonuses to frontline workers.
Apart from these, certain indirect COVID-19 costs like raw materials, transportation, underutilization and reconfiguration of plant, premiums offered to cattle producers and discounts on pricing dragged results.
Segment Details
Beef: Sales in the segment dropped 12.1% to $3,653 million. Sales volume declined 23.8% year over year due to reduced production throughout the quarter stemming from coronavirus. Also, a fall in live cattle harvest capacity due to a temporary facility closure for most parts of the first quarter due to a fire breakout hampered results. Average sales price saw a rise in the quarter, thanks to higher demand amid supply hurdles amid the pandemic.
Pork: Sales in the segment dropped 15.7% year over year to $1,115 million. Sales volume fell 16.5% year over year due to reduced pandemic-led production, even though demand was robust and there was higher availability of live hogs. Average sales price rose due to the same factors that drove pricing in the beef segment.
Chicken: Sales in the segment dropped 6.6% to $3,112 million. Sales volume declined 4.2% on account of lower production and soft foodservice demand, somewhat countered by higher consumer product volumes. Average sales price in the quarter declined due to weak chicken prices stemming from tough market conditions.
Prepared Foods: Sales in the segment slipped 2.6% to $2,035 million. Prepared Foods’ sales volume fell 6% as volume growth in the consumer products business was countered by softness in the foodservice channel and reduced production. Average sales price increased on account of favorable product mix and pass-through of higher raw-material costs.
International/Other: Sales in the segment were $402 million, up 12.9% from $356 million reported in the prior-year quarter. Sales volume improved 25%, whereas average sales price declined.
Other Financial Updates
The company exited the quarter with cash and cash equivalents of $1,365 million, long-term debt of $11,270 million and total shareholders’ equity (including noncontrolling interests) of $15,004 million. In the first nine months of fiscal 2020, cash provided by operating activities was $2,708 million. Management projects capital expenditure to be approximately $1.2 billion for fiscal 2020 and fiscal 2021.
Outlook
For fiscal 2021, USDA expects overall domestic protein production (chicken, beef, pork and turkey) to rise about 1% year over year. Management expects food and protein demand to shift among different sales networks and witness short-term hiccups amid the pandemic. Nonetheless, worldwide demand is expected to increase over time.
The company is battling several hurdles related to the pandemic, which are expected to elevate its operating cost burden and weigh on volumes in the remainder of fiscal 2020 and also fiscal 2021. Tyson Foods expects to continue facing a slowdown in capacity utilization at its production facilities due to member shortages. Moreover, though every segment is seeing a demand shift from food service to retail, retail volume increases have not been enough to compensate for soft foodservice volumes. Consequently, management expects volumes to decline in the fourth quarter of fiscal 2020, especially in its Chicken and Prepared Foods units.
While the company is unable to forecast the impacts of COVID-19 on its short and long-term demand, management said that it is well placed in terms of liquidity to run its business and meet obligations. The company expects its total liquidity to stay above the minimum target of $1 billion.
Segment-Wise Guidance for Fiscal 2021
In the beef segment, USDA projects domestic production to grow about 3% in fiscal 2021. In the fiscal, management anticipates adequate supplies in the markets where its plans operate. For pork, domestic production is likely to rise about 1%, per the USDA. Further, USDA forecasts domestic production in the Chicken segment to be flat to a slight increase from the fiscal 2020 level.
In the Prepared Foods segment, the company expects to remain focused on responding to the changing consumer behavior as it goes into fiscal 2021. Finally, the company expects better results from its operations in the International/Other segment.
TreeHouse Foods (THS - Free Report) has a Zacks Rank #2 and a long-term earnings growth rate of 6.5%.
Flowers Foods (FLO - Free Report) , which carries a Zacks Rank #2 at present, has an impressive earnings surprise record.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Tyson Foods (TSN) Q3 Earnings Beat Estimates, Sales Miss
Tyson Foods, Inc. (TSN - Free Report) posted third-quarter fiscal 2020 results, wherein both earnings and sales declined year over year and the latter fell short of the Zacks Consensus Estimate. Results in the quarter were affected by coronavirus-led reduced production across all segments. Also, the company saw higher-than-usual operating costs in all segments due to COVID-19.
Nevertheless, earnings topped the consensus mark. Also, in a separate press release, management named Dean Banks as the company’s new CEO, who will succeed Noel White on Oct 3. Notably, Banks will continue to serve as the company’s president, while White will serve Tyson Foods as the executive vice chairman of the board of directors.
Shares of the company were up around 2% in the pre-market trading session on Aug 3. Further, this Zacks Rank #2 (Buy) stock has rallied 11.1% in the past three months compared with the industry’s growth of 8.2%.
Q3 in Detail
Adjusted earnings for the reported quarter were $1.40 per share, beating the Zacks Consensus Estimate of 90 cents. However, the bottom line declined 5% year over year.
Tyson Foods, Inc. Price, Consensus and EPS Surprise
Tyson Foods, Inc. price-consensus-eps-surprise-chart | Tyson Foods, Inc. Quote
Net sales declined 7.9% to $10,022 million. Also, the top line fell short of the Zacks Consensus Estimate of $10,605 million.
Gross profit for the quarter came in at $1,313 million, down 1.7% from the prior-year quarter. Tyson Foods’ adjusted operating income decreased 4.5% to $760 million. During the quarter, the company incurred $340 million as direct incremental expenses associated with COVID-19. These include escalated costs related to workers’ health, such as personal protection equipment, sanitization of production facilities, testing for coronavirus, various professional fees and bonuses to frontline workers.
Apart from these, certain indirect COVID-19 costs like raw materials, transportation, underutilization and reconfiguration of plant, premiums offered to cattle producers and discounts on pricing dragged results.
Segment Details
Beef: Sales in the segment dropped 12.1% to $3,653 million. Sales volume declined 23.8% year over year due to reduced production throughout the quarter stemming from coronavirus. Also, a fall in live cattle harvest capacity due to a temporary facility closure for most parts of the first quarter due to a fire breakout hampered results. Average sales price saw a rise in the quarter, thanks to higher demand amid supply hurdles amid the pandemic.
Pork: Sales in the segment dropped 15.7% year over year to $1,115 million. Sales volume fell 16.5% year over year due to reduced pandemic-led production, even though demand was robust and there was higher availability of live hogs. Average sales price rose due to the same factors that drove pricing in the beef segment.
Chicken: Sales in the segment dropped 6.6% to $3,112 million. Sales volume declined 4.2% on account of lower production and soft foodservice demand, somewhat countered by higher consumer product volumes. Average sales price in the quarter declined due to weak chicken prices stemming from tough market conditions.
Prepared Foods: Sales in the segment slipped 2.6% to $2,035 million. Prepared Foods’ sales volume fell 6% as volume growth in the consumer products business was countered by softness in the foodservice channel and reduced production. Average sales price increased on account of favorable product mix and pass-through of higher raw-material costs.
International/Other: Sales in the segment were $402 million, up 12.9% from $356 million reported in the prior-year quarter. Sales volume improved 25%, whereas average sales price declined.
Other Financial Updates
The company exited the quarter with cash and cash equivalents of $1,365 million, long-term debt of $11,270 million and total shareholders’ equity (including noncontrolling interests) of $15,004 million. In the first nine months of fiscal 2020, cash provided by operating activities was $2,708 million. Management projects capital expenditure to be approximately $1.2 billion for fiscal 2020 and fiscal 2021.
Outlook
For fiscal 2021, USDA expects overall domestic protein production (chicken, beef, pork and turkey) to rise about 1% year over year. Management expects food and protein demand to shift among different sales networks and witness short-term hiccups amid the pandemic. Nonetheless, worldwide demand is expected to increase over time.
The company is battling several hurdles related to the pandemic, which are expected to elevate its operating cost burden and weigh on volumes in the remainder of fiscal 2020 and also fiscal 2021. Tyson Foods expects to continue facing a slowdown in capacity utilization at its production facilities due to member shortages. Moreover, though every segment is seeing a demand shift from food service to retail, retail volume increases have not been enough to compensate for soft foodservice volumes. Consequently, management expects volumes to decline in the fourth quarter of fiscal 2020, especially in its Chicken and Prepared Foods units.
While the company is unable to forecast the impacts of COVID-19 on its short and long-term demand, management said that it is well placed in terms of liquidity to run its business and meet obligations. The company expects its total liquidity to stay above the minimum target of $1 billion.
Segment-Wise Guidance for Fiscal 2021
In the beef segment, USDA projects domestic production to grow about 3% in fiscal 2021. In the fiscal, management anticipates adequate supplies in the markets where its plans operate. For pork, domestic production is likely to rise about 1%, per the USDA. Further, USDA forecasts domestic production in the Chicken segment to be flat to a slight increase from the fiscal 2020 level.
In the Prepared Foods segment, the company expects to remain focused on responding to the changing consumer behavior as it goes into fiscal 2021. Finally, the company expects better results from its operations in the International/Other segment.
Looking for More Food Stocks? Check These
Kraft Heinz (KHC - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy), has a long-term earnings growth rate of 6%. You can see the complete list of today’s Zacks #1 Rank stocks here.
TreeHouse Foods (THS - Free Report) has a Zacks Rank #2 and a long-term earnings growth rate of 6.5%.
Flowers Foods (FLO - Free Report) , which carries a Zacks Rank #2 at present, has an impressive earnings surprise record.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>